21 results
Thumbnail

D2.283 - Efficacy and safety of remibrutinib in adults with IgE-mediated peanut allergy: A Phase 2 study

Thumbnail

D2.286 - High Prevalence of Clinical Tolerance to Avoided Foods in LTP-Sensitized Patients

Thumbnail

D2.287 - Clinical characterization and predictors of diagnosis and severity in sunflower seed allergy in a pediatric population

Thumbnail

D2.276 - Clinical and Immunological Differences in Shellfish Allergy

Thumbnail

D2.278 - Dose-response analysis of remibrutinib in oral food challenge outcomes among adults with IgE-mediated peanut allergy

Thumbnail

D2.280 - Biphasic anaphylaxis due to psyllium (Plantago ovata) allergy, the primary component of a plant-based sausage

Thumbnail

D2.281 - Ensemble Immunoinformatic Prediction Reveals Novel Allergen Candidates in Nigella sativa Seeds and Oil

Thumbnail

D2.284 - Peanut Materials Used for Immunoassay Calibration Exhibit Distinct Allergen Profiles

Thumbnail

D2.285 - Baked egg oral Immunotherapy as an alternative in patients who failed raw egg oral immunotherapy

Thumbnail

D2.541 - Healthy and unhealthy plant-based dietary patterns and asthma: a systematic review using validated dietary indices

Thumbnail

D2.542 - Prevalance and risk factors of atopic dermatitis among preschool children Gaziantep, a province in South-Eastern Turkey

Thumbnail

D2.540 - Nationwide Analysis of Domestic Mites in Germany

Thumbnail

D2.544 - Validation of the Turkish Version of the Mastocytosis Control Test

Thumbnail

D3.213 - Sustained effectiveness of the 300 IR house dust mite sublingual tablet over 2 treatment years in a real-world data setting – results of a non-interventional study

Thumbnail

D3.198 - Challenges of using clinical scores as primary endpoints in allergology trials

Thumbnail

D3.199 - Severe systemic allergic reaction following violation of elimination diet in a patient with sensitization despite achieved remission on allergen-specific immunotherapy

Thumbnail

D3.200 - Broad profile of olive pollen sensitisation as a key factor in immunotherapy failure

Thumbnail

D3.201 - Subcutaneous immunotherapy with a depigmented cat allergoid is safe in patients with cat allergy and beneficial for mental health in adolescents

Thumbnail

D3.205 - Two-year Outcomes of Multiple Low-Dose Oral Immunotherapies for combination of Tree Nuts or Peanut for Severe Allergy Patients

Thumbnail

D3.207 - Symptomatology and Sensitization Profiles of Patients Undergoing Subcutaneous Immunotherapy for Aeroallergens in Greece